7. Common Stock

The Company is authorized under its articles of incorporation, as amended, to issue up to 500,000,000 shares of common stock, par value $0.001 per share.

Common Stock Issuances during the year ended December 31, 2025

During January, March, and August 2025, the Company issued 6,049 shares of common stock for alternative cashless exercises of Class F Common Stock Warrants.

During February and October 2025, the Company issued 36,144 shares of common stock for RSA grants to employees, directors, and a consultant.

During May 2025, the Company issued 8,036 shares of common stock in connection with the May 2025 Public Offering, for which the Company received net cash proceeds of $3.4 million.

During May and June 2025, the Company issued 35,298 shares of common stock for cash exercises of pre-funded common stock warrants issued in the May 2025 Public Offering for cash proceeds of $297.

During July 2025, the Company issued 5,893 shares of common stock for cash exercises of Class H Common Stock Warrants, for which the Company received net proceeds of $363,000.

Between September and December 2025, the Company issued 128,655 shares of common stock in connection with the Class H Warrant Inducement, for net cash proceeds of $8.7 million.

Common Stock Issuances during the nine months ended September 30, 2026

During January 2026, the Company released from abeyance 26,881 shares of common stock.

During January 2026, the Company issued 305,180 shares of common stock in connection with the Class I Warrant Inducement, for net cash proceeds of $6.7 million.

During July 2026, the Company issued 10,718 shares of common stock for vested RSUs.

During August 2026, the Company issued 114,333 RSA grants to employees, directors, and a consultant.

As of September 30, 2026 and December 31, 2025, 683,442 and 226,330 shares of common stock were issued and outstanding, respectively. As of September 30, 2026, no cash dividends have been declared or paid.